Stock 6744 FENG CHI BIOTECH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Feng Chi Biotech Corp.

Equities

6744

TW0006744006

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-21 EDT 		5-day change 1st Jan Change
22.7 TWD -0.22% Intraday chart for Feng Chi Biotech Corp. -1.30% +2.25%
04-08 Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 508.2 454.3 381.2 308 341.9
Enterprise Value (EV) 1 316.1 240.3 153.4 86.47 136.7
P/E ratio 28.4 x 18 x 16.5 x 12.5 x 15.1 x
Yield 2.73% 3.9% 5.05% 6.75% 4.73%
Capitalization / Revenue 2.92 x 2.54 x 2.09 x 1.59 x 1.89 x
EV / Revenue 1.81 x 1.34 x 0.84 x 0.45 x 0.76 x
EV / EBITDA 11.5 x 6.72 x 4.72 x 2.82 x 4.77 x
EV / FCF 21.3 x 8.17 x 4.99 x 3.65 x 9.15 x
FCF Yield 4.69% 12.2% 20% 27.4% 10.9%
Price to Book 2.38 x 2.02 x 1.65 x 1.31 x 1.44 x
Nbr of stocks (in thousands) 15,400 15,400 15,400 15,400 15,400
Reference price 2 33.00 29.50 24.75 20.00 22.20
Announcement Date 20-04-16 21-04-09 22-05-25 23-04-25 24-04-08
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 148.1 174.3 178.9 182.6 193.5 180.6
EBITDA 1 25.69 27.59 35.77 32.53 30.67 28.66
EBIT 1 18.72 20.1 28.58 26.44 27.07 24.16
Operating Margin 12.64% 11.53% 15.98% 14.48% 13.99% 13.38%
Earnings before Tax (EBT) 1 20.66 21.69 29.83 28.06 30.42 27.3
Net income 1 16.8 17.36 25.39 23.14 24.61 22.79
Net margin 11.35% 9.96% 14.19% 12.67% 12.72% 12.62%
EPS 2 1.300 1.160 1.640 1.500 1.598 1.470
Free Cash Flow 1 31.58 14.83 29.4 30.74 23.7 14.95
FCF margin 21.32% 8.51% 16.43% 16.84% 12.25% 8.28%
FCF Conversion (EBITDA) 122.9% 53.75% 82.2% 94.48% 77.27% 52.17%
FCF Conversion (Net income) 187.89% 85.42% 115.78% 132.87% 96.27% 65.59%
Dividend per Share 2 0.9000 0.9000 1.150 1.250 1.350 1.050
Announcement Date 19-06-24 20-04-16 21-04-09 22-05-25 23-04-25 24-04-08
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 162 192 214 228 222 205
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 31.6 14.8 29.4 30.7 23.7 15
ROE (net income / shareholders' equity) 10.2% 8.89% 11.6% 10.2% 10.6% 9.62%
ROA (Net income/ Total Assets) 5.59% 5% 6.48% 5.79% 5.69% 4.96%
Assets 1 300.8 346.9 391.8 399.5 432.9 459.9
Book Value Per Share 2 12.70 13.90 14.60 15.00 15.30 15.50
Cash Flow per Share 2 6.000 2.610 3.070 3.170 4.280 1.990
Capex 1 0.42 4.42 3.07 1.1 0.09 1.4
Capex / Sales 0.28% 2.54% 1.71% 0.6% 0.05% 0.77%
Announcement Date 19-06-24 20-04-16 21-04-09 22-05-25 23-04-25 24-04-08
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Advanced Medical Equipment Wholesale

1st Jan change Capi.
FENG CHI BIOTECH CORP. Stock Feng Chi Biotech Corp.
+2.25% 10.82M
CHC HEALTHCARE GROUP Stock CHC Healthcare Group
-14.08% 271M
ILEX MEDICAL LTD Stock Ilex Medical Ltd
+5.27% 190M
MEDICAL IMAGING CORPORATION Stock Medical Imaging Corporation
+33.73% 73.71M
Advanced Medical Equipment Wholesale
  1. Stock Market
  2. Equities
  3. 6744 Stock
  4. Financials Feng Chi Biotech Corp.